US Patent 9783825 Recombinant adeno-associated vectors for targeted treatment
Patent 9783825 was granted and assigned to City of Hope on October, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9783825 Recombinant adeno-associated vectors for targeted treatment
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
